SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-157307
Filing Date
2023-05-31
Accepted
2023-05-31 08:16:01
Documents
19
Period of Report
2023-05-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d476076d8k.htm   iXBRL 8-K 33018
2 EX-1.1 d476076dex11.htm EX-1.1 217902
3 EX-4.1 d476076dex41.htm EX-4.1 69301
4 EX-5.1 d476076dex51.htm EX-5.1 8590
5 EX-99.1 d476076dex991.htm EX-99.1 9199
6 EX-99.2 d476076dex992.htm EX-99.2 10260
10 GRAPHIC g476076g0530233830434.jpg GRAPHIC 2668
11 GRAPHIC g476076g36q97.jpg GRAPHIC 11656
  Complete submission text file 0001193125-23-157307.txt   572697

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA tcrx-20230525.xsd EX-101.SCH 2844
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcrx-20230525_lab.xml EX-101.LAB 17978
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcrx-20230525_pre.xml EX-101.PRE 11254
13 EXTRACTED XBRL INSTANCE DOCUMENT d476076d8k_htm.xml XML 3351
Mailing Address 880 WINTER STREET WALTHAM MA 02451
Business Address 880 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Filer) CIK: 0001783328 (see all company filings)

IRS No.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40603 | Film No.: 23979030
SIC: 2836 Biological Products, (No Diagnostic Substances)